SOHM, Inc. Secures Key Patent for Revolutionary Gene Editing Technology
New Delhi, December 03, 2024: SOHM, Inc., a globally recognised pharmaceutical company focused on developing, manufacturing and distributing Generic, Branded Generic, Private label, and Sohm-innovated Pharmaceuticals, Cosmeceuticals and Nutraceutical products, announced the approval of a critical patent by the Japan Patent Office (JPO). This patent safeguards SOHM’s pioneering ABBIE (A Base Binding Integrase Enzyme) genome…
Read More “SOHM, Inc. Secures Key Patent for Revolutionary Gene Editing Technology” »
